Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26461191 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL3134777 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL29691723 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL28666981 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL11925454 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL3134783 | 1.00 | FASN (0.61) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL5912076 | 0.98 | FASN (0.63) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL7749287 | 0.98 | FASN (0.63) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL4732258 | 0.98 | FASN (0.63) | FASNKDM4EALDH1A1TSHRCNR1 | |
| SCHEMBL21858122 | 0.98 | FASN (0.63) | FASNKDM4EALDH1A1TSHRCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10183922-B2 | Methods and compositions for wound healing | QBIOTICS LIMITED (AU) | 2019-01-22 | — | — | US | disclosed |
| US-20170144981-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | QBIOTICS LIMITED (AU) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10183922-B2 | Methods and compositions for wound healing | PTGES3, ELANE, PTGES | FASN 7/4885KDM4E 776/4885ALDH1A1 330/4885 |
| US-20170144981-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | PTGES3, ELANE, PTGES | FASN 7/4885KDM4E 776/4885ALDH1A1 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.